Log in or Sign up for Free to view tailored content for your specialty!
Vasculitis and Giant Cell Arteritis News
Patients with prior sinusitis have greater rheumatic disease risk
Patients with prior sinusitis demonstrate an increased risk for many rheumatic diseases, including antiphospholipid syndrome, Sjögren’s disease and seronegative rheumatoid arthritis, according to data published in RMD Open.
Benralizumab non-inferior to mepolizumab for eosinophilic granulomatosis with polyangiitis
Benralizumab is noninferior to mepolizumab in achieving remission of relapsing or refractory eosinophilic granulomatosis with polyangiitis at 36 and 48 weeks, according to data published in The New England Journal of Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Patients with higher apolipoprotein A-I levels at greater risk for giant cell arteritis
Patients who eventually developed giant cell arteritis demonstrated significantly higher levels of apolipoprotein A-I at baseline, according to population-based data published in Arthritis Research & Therapy.
FDA approves second tocilizumab biosimilar; first available in IV, subcutaneous forms
The FDA has approved Tyenne, the second tocilizumab biosimilar overall and the first available in both intravenous and subcutaneous formulations, according to a press release from its manufacturer.
IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth
Pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although immune-mediated inflammatory diseases in general are “only weakly associated” with adverse pregnancy outcomes, according to data.
A rare day for rare diseases: Latest data and findings for Rare Disease Day
It’s not too often one sees Feb. 29 on the calendar, which makes it a perfect time for Rare Disease Day, dedicated to recognizing conditions that, in the words of the European Commission on Public Health, require “special combined efforts.”
‘Astounding amount’ of vasculitis trials opens mixed bag of ‘exciting,’ ‘frustrating’ data
SCOTTSDALE, Ariz. — Recent efforts in vasculitis research have seen both “exciting” and “frustrating” results, according to data presented at the Basic and Clinical Immunology for the Busy Clinician symposium.
VIDEO: Research should focus on maintenance, long-term management of vasculitis
In this video, Audra Horomanski, MD, spoke with Healio about challenges in the vasculitis space.
VIDEO: ‘Onus’ on providers to educate patients on vasculitis
In this video, Audra Horomanski, MD, discusses improving awareness of vasculitis management through provider education.
VIDEO: Collaborative care ‘cornerstone’ of vasculitis management
In this video, Audra Horomanski, MD, discusses the importance of collaborative care in the treatment and maintenance of patients with vasculitis.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read